Jorgé Duconge

2.2k total citations
128 papers, 1.4k citations indexed

About

Jorgé Duconge is a scholar working on Pharmacology, Oncology and Materials Chemistry. According to data from OpenAlex, Jorgé Duconge has authored 128 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Pharmacology, 19 papers in Oncology and 19 papers in Materials Chemistry. Recurrent topics in Jorgé Duconge's work include Pharmacogenetics and Drug Metabolism (35 papers), Antiplatelet Therapy and Cardiovascular Diseases (15 papers) and Drug Transport and Resistance Mechanisms (10 papers). Jorgé Duconge is often cited by papers focused on Pharmacogenetics and Drug Metabolism (35 papers), Antiplatelet Therapy and Cardiovascular Diseases (15 papers) and Drug Transport and Resistance Mechanisms (10 papers). Jorgé Duconge collaborates with scholars based in Puerto Rico, United States and Spain. Jorgé Duconge's co-authors include Francisco Márquez, Gualberto Ruaño, María Cotto, Michael J. González, Jorge R. Miranda-Massari, Carmen Morant, Abniel Machín, Neil H Riordan, Carmen L. Cadilla and Stuart A. Scott and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The FASEB Journal.

In The Last Decade

Jorgé Duconge

121 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jorgé Duconge Puerto Rico 21 336 223 220 179 153 128 1.4k
Xiaoqian Wu China 23 129 0.4× 757 3.4× 135 0.6× 82 0.5× 60 0.4× 78 1.8k
Kexin Wang China 25 64 0.2× 460 2.1× 310 1.4× 394 2.2× 166 1.1× 201 2.3k
Karluss Thomas United States 16 444 1.3× 529 2.4× 651 3.0× 34 0.2× 141 0.9× 20 2.8k
Tomáš Roušar Czechia 18 247 0.7× 338 1.5× 180 0.8× 55 0.3× 100 0.7× 60 1.3k
Jialin Xu China 29 150 0.4× 878 3.9× 119 0.5× 62 0.3× 91 0.6× 84 2.3k
Yuhan Tang China 29 119 0.4× 787 3.5× 204 0.9× 51 0.3× 103 0.7× 102 3.0k
Mi Li China 25 218 0.6× 999 4.5× 98 0.4× 70 0.4× 237 1.5× 118 2.1k
Shasha Song China 28 146 0.4× 949 4.3× 465 2.1× 58 0.3× 239 1.6× 105 2.7k
Shu Zhou China 27 377 1.1× 1.1k 4.8× 275 1.3× 55 0.3× 505 3.3× 86 2.8k
Srikumar Chakravarthi Malaysia 23 208 0.6× 315 1.4× 126 0.6× 20 0.1× 73 0.5× 96 1.6k

Countries citing papers authored by Jorgé Duconge

Since Specialization
Citations

This map shows the geographic impact of Jorgé Duconge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jorgé Duconge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jorgé Duconge more than expected).

Fields of papers citing papers by Jorgé Duconge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jorgé Duconge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jorgé Duconge. The network helps show where Jorgé Duconge may publish in the future.

Co-authorship network of co-authors of Jorgé Duconge

This figure shows the co-authorship network connecting the top 25 collaborators of Jorgé Duconge. A scholar is included among the top collaborators of Jorgé Duconge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jorgé Duconge. Jorgé Duconge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Duconge, Jorgé, et al.. (2023). An Expiration Date for Pharmacogenetic Test Results and Prescribing Guidance?. The Journal of Applied Laboratory Medicine. 8(4). 826–830. 1 indexed citations
4.
Machín, Abniel, María Cotto, Jorgé Duconge, et al.. (2023). Sensitive and Reversible Ammonia Gas Sensor Based on Single-Walled Carbon Nanotubes. Chemosensors. 11(4). 247–247. 6 indexed citations
5.
González, Ángel, et al.. (2022). Experiences and Preferences of Opioid-Use-Disorder Patients Who Switched from Brand to Generic Buprenorphine/Naloxone Films: A Case Series. SHILAP Revista de lepidopterología. 3 indexed citations
6.
Hernández-Suárez, Dagmar F., Sona Rivas‐Tumanyan, Hetanshi Naik, et al.. (2020). Implementing a pharmacogenetic-driven algorithm to guide dual antiplatelet therapy (DAPT) in Caribbean Hispanics: protocol for a non-randomised clinical trial. BMJ Open. 10(8). e038936–e038936. 11 indexed citations
7.
Maldonado, María del Mar, Jorgé Duconge, Jean F. Ruiz-Calderón, et al.. (2019). Pharmacokinetics of the Rac/Cdc42 Inhibitor MBQ-167 in Mice by Supercritical Fluid Chromatography–Tandem Mass Spectrometry. ACS Omega. 4(19). 17981–17989. 12 indexed citations
8.
Hernández-Suárez, Dagmar F., Mariana Rodrigues Botton, Stuart A. Scott, et al.. (2018). Pharmacogenetic association study on clopidogrel response in Puerto Rican Hispanics with cardiovascular disease: a novel characterization of a Caribbean population. Pharmacogenomics and Personalized Medicine. Volume 11. 95–106. 6 indexed citations
9.
Miranda-Massari, Jorge R., et al.. (2017). Role of treatment-modifying MTHFR 677C>T and 1298A>C polymorphisms in metformin-treated Puerto Rican patients with type-2 diabetes mellitus and peripheral neuropathy. Drug Metabolism and Personalized Therapy. 32(1). 23–32. 4 indexed citations
10.
Corey, S., et al.. (2015). Pharmacogenetics of healthy volunteers in Puerto Rico. Drug Metabolism and Personalized Therapy. 30(4). 239–249. 7 indexed citations
11.
Duconge, Jorgé, et al.. (2014). Population Heterogeneity and Genomic Admixture: Relevance for Global Pharmacogenetics. 5(5). 3 indexed citations
12.
Duconge, Jorgé, Scott D. Grosse, Rodney Presley, et al.. (2014). Abstract Proceedings of the 2014 Thrombosis and Hemostasis Summit of North America. American Journal of Hematology. 89(6). 3 indexed citations
13.
Duconge, Jorgé, et al.. (2014). Pharmacogenetics of drug-metabolizing enzymes in US Hispanics. Drug Metabolism and Personalized Therapy. 30(2). 87–105. 24 indexed citations
14.
Duconge, Jorgé, Carmen L. Cadilla, Andreas Windemuth, et al.. (2009). Prevalence of combinatorial CYP2C9 and VKORC1 genotypes in Puerto Ricans: implications for warfarin management in Hispanics.. PubMed. 19(4). 390–5. 16 indexed citations
15.
Cotto, María, et al.. (2009). Degradation of phenol by mechanical activation of a rutile catalyst. Journal of Colloid and Interface Science. 339(1). 133–139. 6 indexed citations
16.
Duconge, Jorgé, et al.. (2002). Monoclonal anti-EGFreceptor antibody (ior-R3) pharmacokinetic study in tumor bearing nude mice: Role of the receptor-mediated endocytosis on drug clearance. European Journal of Drug Metabolism and Pharmacokinetics. 27(2). 101–105. 8 indexed citations
17.
Morales, Alejo A., et al.. (2000). Freeze-dried formulation for the direct 99mTc-labeling of ior egf/r3 monoclonal antibody: equivalence studies. Biotecnología aplicada. 17(1). 39–44. 1 indexed citations
18.
Rodríguez, José Luis, et al.. (2000). Comparative pharmacokinetics and pharmacodynamics of two recombinant human interferon alpha-2b formulations administered intramuscularly in healthy male volunteers. Biotecnología aplicada. 17(3). 166–170. 8 indexed citations
19.
20.
Duconge, Jorgé, et al.. (1982). La categoria didactica, objetivos en la ensenanza de la fisica general en la educacion superior cubana. 2(3). 103–158.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaoqian Wu Breakdown of academic impact, for papers by Kexin Wang Breakdown of academic impact, for papers by Karluss Thomas Breakdown of academic impact, for papers by Tomáš Roušar Breakdown of academic impact, for papers by Jialin Xu Breakdown of academic impact, for papers by Yuhan Tang Breakdown of academic impact, for papers by Mi Li Breakdown of academic impact, for papers by Shasha Song Breakdown of academic impact, for papers by Shu Zhou Breakdown of academic impact, for papers by Srikumar Chakravarthi
Rankless by CCL
2026